secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001213900-23-035978
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q1 2023 revenue $3.4M; net loss $1.9M; expects H2 profitability
--------------------------------------------------------------------------------

- Revenue $3.4M vs $10.3M YoY; shipped 10 SRT systems vs 33.
- Net loss $1.9M ($0.12 per share) vs net income $16.1M ($0.97 per share) in Q1 2022 (included $12.8M gain).
- Gross margin fell to 47.1% from 68.9% due to lower volume and vendor cost increases.
- Ended Q1 with $19.3M cash, no debt; expects >60 SRT shipments in 2023 and return to profitability in H2.
- Management cites inflation impacting dermatologists' cash flow; higher selling & marketing expense.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390023035978/0001213900-23-035978-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390023035978/ea177605-8k_sensus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-035978

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer